XML 43 R26.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Schedule of carrying amounts of the assets, liabilities, the results of operations and cash flows of the VIE and its subsidiaries

The carrying amounts of the assets, liabilities, the results of operations and cash flows of the VIE and VIE’s subsidiaries included in the Company, its subsidiaries, the VIE and VIE subsidiaries’ consolidated financial statements after the elimination of intercompany balances and transactions among the VIE and VIE’s subsidiaries, and the Company and its subsidiaries are as follows:

    

    

September 30, 

September 30, 

2022

2021

ASSETS

  

  

Current assets:

 

  

 

  

Cash and cash equivalents

$

10,027,168

$

4,161,582

Restricted cash

659,779

2,140,016

Accounts receivable, net

 

815,022

 

1,733,306

Bank acceptance receivable

 

2,585,886

 

11,722,096

Inventories, net

 

8,879,486

 

12,495,831

Advances to suppliers, net

 

1,214,951

 

1,380,757

Other current assets

 

1,493,304

 

423,331

Total current assets

 

25,675,596

 

34,056,919

Property and equipment, net

 

9,361,862

 

9,041,995

Intangible assets, net

 

1,726,928

 

1,927,933

Long-term investment

 

617,570

 

639,466

Other long-term assets

 

172,911

 

188,913

Right of use assets-lease

 

86,584

 

118,154

Deferred tax assets

 

212,876

 

427,172

Total assets

$

37,854,327

$

46,400,552

LIABILITIES

 

 

  

Current liabilities:

 

 

  

Bank loans

$

140,578

$

Accounts payable

 

5,266,571

 

6,642,625

Advance from customers

 

556,418

 

2,467,296

Advance from customers - related parties

 

 

17,318

Bank notes payable

1,531,649

7,867,018

Deferred government grants - current

 

121,542

 

351,567

Taxes payable

 

825,301

 

371,325

Operating lease liabilities, current

 

23,859

 

55,847

Accrued expenses and other payables

 

701,263

 

466,188

Total current liabilities

 

9,167,181

 

18,239,184

Operating lease liabilities, long term

 

72,537

 

106,180

Deferred government grants - noncurrent

 

309,943

 

403,745

Total liabilities

 

9,549,661

 

18,749,109

For the year ended

September 30, 

2022

2021

2020

Net revenue

    

$

64,468,807

    

$

57,049,381

    

$

46,731,913

Income from operations

$

2,502,014

$

2,370,647

$

4,840,614

Net income

$

2,752,212

$

2,857,492

$

4,936,357

For the Year Ended

September 30, 

2022

2021

2020

Net cash provided by operating activities

    

$

12,901,270

    

$

2,122,539

    

$

4,131,468

Net cash used in investing activities

 

(1,153,972)

 

(1,781,618)

 

(5,648,762)

Net cash provided by (used in) financing activities

 

(5,937,529)

 

123,697

 

2,140,503

Effect of exchange rate on cash

 

(1,018,698)

 

343,759

 

275,566

Net increase in cash and cash equivalents

$

4,791,071

$

808,377

$

898,775

Schedule of estimated useful lives of the assets

Items

    

Useful life

Property and buildings

 

20–25 years

Leasehold improvement

 

Lesser of useful life and lease term

Machinery and equipment

 

5–10 years

Automobiles

 

3–5 years

Office and electric equipment

 

3–5 years

Schedule of estimated useful lives of intangible assets

Items

    

Useful life

Land use rights

 

50 years

Software

 

10 years

License for drug manufacturing

 

10 years

Schedule of shareholders' equity for the non-controlling interest from each subsidiary that is not 100% owned

The following table summarizes the shareholders’ equity for the non-controlling interest from each subsidiary that is not 100% owned by the Company:

As of

September 30, 

September 30, 

2022

2021

Gansu QLS

    

$

237,397

    

$

240,683

Chengdu QLS and subsidiaries

 

1,673,997

 

1,569,169

Total

$

1,911,394

$

1,809,852

Schedule of computation of basic and diluted earnings per share

The following table sets forth the computation of basic and diluted earnings per share for the years ended September 30, 2022, 2021 and 2020:

For the Years ended September 30,

    

2022

    

2021

    

2020

Numerator:

Net income attributable to ordinary shareholders

$

1,076,693

$

3,152,868

$

5,063,710

Denominator:

 

  

 

  

 

  

Weighted-average number of ordinary shares outstanding – basic

 

35,750,000

 

34,089,286

 

30,000,000

Outstanding warrants

 

 

Potentially dilutive shares from outstanding options and warrants

 

 

 

Weighted-average number of ordinary shares outstanding – diluted

 

35,750,000

 

34,089,286

 

30,000,000

Earnings per share – basic

$

0.03

$

0.09

$

0.17

Earnings per share – diluted

$

0.03

$

0.09

$

0.17

Schedule of currency exchange rates

    

September 30, 2022

    

September 30, 2021

    

September 30, 2020

Year-end spot rate

 

US$1=RMB 7.1135

 

US$1=RMB 6.4580

 

US$1=RMB 6.8033

Average rate

 

US$1=RMB 6.5532

 

US$1=RMB 6.5095

 

US$1=RMB 7.0077

Schedule of reconciliation of the beginning and ending balance of the assets and liabilities measured at fair value on recurring basis

The Company noted no transfers between levels during any of the periods presented.

The following is a reconciliation of the beginning and ending balance of the assets and liabilities measured at fair value on a recurring basis for the year ended September 30, 2022 and 2021:

    

As of

    

As of

September 30,

September 30,

2022

2021

Beginning balance

$

20,323,400

$

Fair value of investment in available-for-sale securities at inception

 

(853,000)

 

20,000,000

Change in fair value

 

 

323,400

Ending balance

$

19,470,400

$

20,323,400